Bio-Rad Laboratories Inc $ 345.24 5.51 (1.62%)
On watch
| Volume: | 415,943 | Avg Vol (1m): | 189,711 |
| Market Cap $: | 10.28 Bil | Enterprise Value $: | 9.94 Bil |
| P/E (TTM): | 11.66 | P/B: | 1.89 |
Manual of Stocks™ Web
Financial Strength | 7.6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 1.49 | ||
| Equity-to-Asset | 0.72 | ||
| Debt-to-Equity | 0.12 | ||
| Debt-to-EBITDA | 0.48 | ||
| Interest Coverage | 8.94 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 4.84 | ||
| Beneish M-Score | -2.77 | ||
| WACC vs ROIC | |||
Profitability | 5/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 9.38 | ||
| Net Margin % | 39.54 | ||
| ROE % | 18.92 | ||
| ROA % | 13.62 | ||
| ROC (Joel Greenblatt) % | 93.64 | ||
| 3-Year Revenue Growth Rate | 3.3 | ||
| 3-Year EBITDA Growth Rate | 29.9 | ||
| 3-Year EPS without NRI Growth Rate | 48.3 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 11.66 | ||
| PE Ratio without NRI | 11.66 | ||
| Price-to-Owner-Earnings | 8.35 | ||
| PB Ratio | 1.89 | ||
| PS Ratio | 4.56 | ||
| Price-to-Free-Cash-Flow | 42.71 | ||
| Price-to-Operating-Cash-Flow | 28.5 | ||
| EV-to-EBIT | 8.08 | ||
| EV-to-EBITDA | 7.18 | ||
| EV-to-Revenue | 4.35 | ||
| PEG Ratio | 1.46 | ||
| Shiller PE Ratio | 34.23 | ||
| Current Ratio | 4.68 | ||
| Quick Ratio | 3.36 | ||
| Days Inventory | 205.6 | ||
| Days Sales Outstanding | 60.27 | ||
| Days Payable | 85.81 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.8 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 2.03 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 1.92 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 1.09 | ||
| Price-to-Median-PS-Value | 2.73 | ||
| Price-to-Peter-Lynch-Fair-Value | 0.47 | ||
| Price-to-Graham-Number | 1.03 | ||
| Earnings Yield (Greenblatt) % | 12.37 | ||
| Forward Rate of Return (Yacktman) % | 21.03 |